$131.76
▼ $3.49 (-2.6%)
GILD
Gilead Sciences
Health Care
Investor Score
67B-
Moderate rating
Based on 7 of 7 weighted categories, computed from real, live financial data only.
69
Technical
79
Fundamental
62
Growth
38
Fair Value
100
News
58
Quality
56
Risk
Want the full breakdown — DCF fair value, technical indicators, news sentiment, and an AI-written narrative explaining this score?
View the full analysis (Hebrew) ←All raw data comes from real commercial financial data providers. This page is for educational purposes only and is not investment advice.